Successful use of extracorporeal membrane oxygenation in an adult patient with toxic shock-induced heart failure

Journal of Intensive Care Medicine

Volumn 30, Issue 2, 2015, Pages 115-118

  Gabel, Eilon ^a   Gudzenko, Vadim ^a   Cruz, Daniel ^a   Ardehali, Abbas ^a   Fink, Mitchell P ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Surgery ^*  (United States)

Author keywords

cardiomyopathy; ECMO; heart failure; sepsis; toxic shock syndrome

Indexed keywords

CLINDAMYCIN; DOBUTAMINE; DOPAMINE; DOXYCYCLINE; FLUCONAZOLE; IMMUNOGLOBULIN; INFUSION FLUID; NORADRENALIN; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN; VASOPRESSIN; ANTIINFECTIVE AGENT;

ADULT; ARTICLE; CARDIOMYOPATHY; CASE REPORT; EXTRACORPOREAL OXYGENATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; TOXIC SHOCK SYNDROME; TREATMENT OUTCOME; ARTIFICIAL VENTILATION; EXUDATE; HEMODYNAMICS; IMMUNOLOGY; INTENSIVE CARE UNIT; LEG ULCER; MICROBIOLOGY; PATHOPHYSIOLOGY; SHOCK, CARDIOGENIC; SHOCK, SEPTIC; STAPHYLOCOCCAL SKIN INFECTION; STREPTOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; EXTRACORPOREAL MEMBRANE OXYGENATION; EXUDATES AND TRANSUDATES; HEMODYNAMICS; HUMANS; INTENSIVE CARE UNITS; LEG ULCER; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; RESPIRATION, ARTIFICIAL; SHOCK, CARDIOGENIC; SHOCK, SEPTIC; STAPHYLOCOCCAL SKIN INFECTIONS; STREPTOCOCCAL INFECTIONS; TREATMENT OUTCOME;

EID: 84920992155     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066613517069     Document Type: Article

References (20)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001 ; 29 (7). 1303-1310
2. Packman MI, Rackow EC. Optimum left heart filling pressure during fluid resuscitation of patients with hypovolemic and septic shock. Crit Care Med. 1983 ; 11 (3). 165-169
3. Todd J, Fishaut M, Kapral F, Welch T. Toxic-shock syndrome associated with phage-group-I Staphylococci. Lancet. 1978 ; 2 (8100). 1116-1118
4. Davis JP, Chesney PJ, Wand PJ, LaVenture M. Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention. N Engl J Med. 1980 ; 303 (25). 1429-1435
5. Shands KN, Schmid GP, Dan BB, et al. Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med. 1980 ; 303 (25). 1436-1442
6. Burns JR, Menapace FJ. Acute reversible cardiomyopathy complicating toxic shock syndrome. Arch Intern Med. 1982 ; 142 (5). 1032-1034
7. Fisher CJ, Horowitz Z, Albertson TE. Cardiorespiratory failure in toxic shock syndrome: effect of dobutamine. Crit Care Med. 1985 ; 13 (3). 160-165
8. Crews JR, Harrison JK, Corey GR, Steenbergen C, Bashore TM. Stunned myocardium in the toxic shock syndrome. Ann Intern Med. 1992 ; 117 (11). 912-913
9. Rastan AJ, Dege A, Mohr M, et al. Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. J Thorac Cardiovasc Surg. 2010 ; 139 (2). 302-311-311.e1
10. Doll N, Kiaii B, Borger M, et al. Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock. Ann Thorac Surg. 2004 ; 77 (1). 151-157
11. MacLaren G, Butt W, Best D, Donath S. Central extracorporeal membrane oxygenation for refractory pediatric septic shock. Pediatr Crit Care Med. 2011 ; 12 (2). 133-136
12. Mugford M, Elbourne D, Field D. Extracorporeal membrane oxygenation for severe respiratory failure in newborn infants. Cochrane Database Syst Rev. 2008 ; (3). CD001340
13. Brierley J, Carcillo JA, Choong K, et al. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American college of critical care medicine. Crit Care Med. 2009 ; 37 (2). 666-688
14. MacLaren G, Pellegrino V, Butt W, Preovolos A, Salamonsen R. Successful use of ECMO in adults with life-threatening infections. Anaesth Intensive Care. 2004 ; 32 (5). 707-710
15. Rich PB, Younger JG, Soldes OS, Awad SS, Bartlett RH. Use of extracorporeal life support for adult patients with respiratory failure and sepsis. ASAIO J. 1998 ; 44 (4). 263-266
16. Vohra HA, Adamson L, Weeden DF, Haw MP. Use of extracorporeal membrane oxygenation in the management of septic shock with severe cardiac dysfunction after Ravitch procedure. Ann Thorac Surg. 2009 ; 87 (1). e4 - e5
17. Cheng A, Sun HY, Lee CW, et al. Survival of septic adults compared with nonseptic adults receiving extracorporeal membrane oxygenation for cardiopulmonary failure: a propensity-matched analysis. J Crit Care. 2013 ; 28 (4). 532.e1-10
18. Bréchot N, Luyt C-E, Schmidt M, et al. Venoarterial extracorporeal membrane oxygenation support for refractory cardiovascular dysfunction during severe bacterial septic shock. Crit Care Med. 2013 ; 41 (7). 1616-1626
19. MacLaren G, Butt W. Extracorporeal membrane oxygenation and sepsis. Crit Care Resusc. 2007 ; 9 (1). 76-80
20. Firstenberg MS, Abel E, Blais D, et al. The use of extracorporeal membrane oxygenation in severe necrotizing soft tissue infections complicated by septic shock. Am Surg. 2010 ; 76 (11). 1287-1289